Distributed

No. 25-257

Wells Pharma of Houston, L.L.C. v. Zyla Life Sciences, L.L.C.

from the United States Court of Appeals for the Fifth Circuit

See other cases from the Fifth Circuit.

Docket Entries

The Solicitor General is invited to file a brief in this case expressing the views of the United States.

DISTRIBUTED for Conference of 1/9/2026.

Reply of petitioner Wells Pharma of Houston, L.L.C. filed.

Brief of respondent Zyla Life Sciences, L.L.C. in opposition filed.

Brief amicus curiae of Outsourcing Facilities Association filed.

Motion to extend the time to file a response is granted and the time is extended to and including November 17, 2025.

Motion to extend the time to file a response from October 27, 2025 to November 17, 2025, submitted to The Clerk.

Brief amicus curiae of Americans for Access to Compounded Medication filed.

Response Requested. (Due October 27, 2025)

DISTRIBUTED for Conference of 10/10/2025.

Waiver of right of respondent Zyla Life Sciences, L.L.C. to respond filed.

Petition for a writ of certiorari filed. (Response due October 6, 2025)

Parties

Wells Pharma of Houston, L.L.C., Petitioner, represented by Jeremy Thomas Grabill

Zyla Life Sciences, L.L.C., Respondent, represented by Jeffrey S. Bucholtz

Amici Curiae

Americans for Access to Compounded Medications, Amicus Curiae, represented by Mark Daniel Boesen

Outsourcing Facilities Association, Amicus Curiae, represented by Andrew Michael Grossman

 
Last updated: April 18, 2026